Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
Public ClinicalTrials.gov record NCT00004981. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIIB Randomized, Multicenter Study of the Efficacy and Safety of Combivir 1 Tablet Po Bid Plus Ziagen 300mg Po Bid Versus an Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg Combination Tablet Po Bid, Administered for 24 Weeks in Subjects With HIV-1 Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to look at the safety and effectiveness of a pill called Trizivir that is a combination of three anti-HIV drugs (zidovudine, lamivudine, and abacavir). Zidovudine and lamivudine are often given combined in one pill (Combivir). In this study, Trizivir will be compared to Combivir plus abacavir.
Study identification
- NCT ID
- NCT00004981
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 230 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 25
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AIDS Healthcare Foundation | Los Angeles | California | 900276069 | — |
| Tower Infectious Disease Med Ctr | Los Angeles | California | 90048 | — |
| Robert Scott MD | Oakland | California | 94609 | — |
| St Lukes Medical Group | San Diego | California | 92101 | — |
| Georgetown Univ Med Ctr | Washington D.C. | District of Columbia | 20007 | — |
| Whitman Walker Clinic | Washington D.C. | District of Columbia | 20009 | — |
| Univ of Miami School of Medicine | Miami | Florida | 33136 | — |
| Specialty Med Care Ctrs of South Florida Inc | Miami | Florida | 33142 | — |
| Saint Josephs Comprehensive Research Institute | Tampa | Florida | 33607 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Rush Presbyterian - Saint Luke's Med Ctr | Chicago | Illinois | 60612 | — |
| New England Med Ctr | Boston | Massachusetts | 02111 | — |
| Research Med Ctr | Kansas City | Missouri | 64111 | — |
| Addiction Research and Treatment Corp | Brooklyn | New York | 11201 | — |
| Saint Vincent's Hosp and Med Ctr | New York | New York | 10011 | — |
| St Luke Roosevelt Hosp | New York | New York | 10011 | — |
| Lehigh Valley Hosp | Allentown | Pennsylvania | 18105 | — |
| Hahnemann Univ Hosp | Philadelphia | Pennsylvania | 191021192 | — |
| Anderson Clinical Research | Pittsburgh | Pennsylvania | 15213 | — |
| Burnside Clinic | Columbia | South Carolina | 29206 | — |
| Univ of Tennessee | Memphis | Tennessee | 38163 | — |
| Nashville Health Management Foundation / Vanderbilt Univ | Nashville | Tennessee | 37203 | — |
| Nicholas Bellos | Dallas | Texas | 75246 | — |
| Univ of Texas Med Branch | Galveston | Texas | 77555 | — |
| Therapeutic Concepts | Houston | Texas | 77004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00004981, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00004981 live on ClinicalTrials.gov.